VanEck Pharmaceutical ETF Rating $94.51 0.00 (0.00%) Closing price 03/7/2025 04:00 PM EasternExtended Trading$94.52 +0.02 (+0.02%) As of 03/7/2025 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.70Holdings in PPH have an aggregate rating of Moderate Buy based on 272 analyst ratings issued in the past year covering 23 companies (95.1% of the portfolio).PPH Aggregate Price Target$94.51High Prediction$94.51Average Prediction$94.51Low Prediction$94.51Holdings in PPH have an aggregate price target of $94.51 and a range of $94.51 to $94.51 covering 23 companies (95.1% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce3 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings14.66%LLYEli Lilly and Company$868.59-4.8%4.5552 of 5 stars2.85$1,007.50 16.0%20Positive News7.40%JNJJohnson & Johnson$166.81+0.6%4.7432 of 5 stars2.56$171.33 2.7%18Positive News7.33%ABBVAbbVie$214.55+1.8%4.5112 of 5 stars2.88$211.45 -1.4%24Positive News6.49%NVONovo Nordisk A/S$87.19-1.0%4.574 of 5 stars2.78$145.25 66.6%95.46%AZNAstraZeneca$77.50+0.0%2.9066 of 5 stars3.10$89.75 15.8%10Positive News5.34%NVSNovartis$115.60+2.4%1.9541 of 5 stars1.80$123.38 6.7%10Positive News4.94%SNYSanofi$59.25-0.3%2.9662 of 5 stars3.25$60.00 1.3%4Analyst Revision4.74%GSKGSK$40.08+2.0%1.7463 of 5 stars2.60$43.25 7.9%104.71%MCKMcKesson$644.92+0.5%4.4938 of 5 stars2.93$645.79 0.1%15Positive News4.70%CORCencora$254.54+0.3%4.2121 of 5 stars2.80$277.90 9.2%10Positive News4.58%MRKMerck & Co., Inc.$94.71+0.8%4.9956 of 5 stars2.58$116.39 22.9%24High Trading Volume4.54%BMYBristol-Myers Squibb$61.16+1.6%4.5116 of 5 stars2.30$57.86 -5.4%20Dividend AnnouncementPositive News4.53%PFEPfizer$26.71+1.8%4.9846 of 5 stars2.50$31.92 19.5%16Positive News4.39%HLNHaleon$10.45+0.5%1.228 of 5 stars2.50$10.95 4.8%8Dividend Increase4.08%ZTSZoetis$170.34+1.8%4.9203 of 5 stars3.08$215.90 26.7%12Analyst UpgradeAnalyst RevisionPositive News2.95%TEVATeva Pharmaceutical Industries$15.34-0.1%2.9933 of 5 stars2.86$23.43 52.7%7Analyst DowngradeAnalyst Revision1.36%VTRSViatris$9.65+1.5%1.4685 of 5 stars1.75$10.50 8.8%4Analyst Forecast1.08%JAZZJazz Pharmaceuticals$138.81+1.7%4.8626 of 5 stars2.93$189.40 36.4%15Analyst UpgradeInsider TradeGap Up0.47%ELANElanco Animal Health$11.12+2.7%3.9949 of 5 stars2.43$15.17 36.4%70.47%OGNOrganon & Co.$15.44+3.9%4.8391 of 5 stars2.43$20.80 34.7%7Positive News0.36%PRGOPerrigo$27.81-3.0%4.6134 of 5 stars2.25$33.00 18.7%4Ex-DividendPositive News0.28%PDCOPatterson Companies$31.13+0.0%4.2312 of 5 stars2.09$26.57 -14.6%11Positive News0.27%BHCBausch Health Companies$7.14-1.0%3.1616 of 5 stars1.86$7.42 3.9%7Positive News This page (NASDAQ:PPH) was last updated on 3/10/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPH Stock Alerts